Immunocore Holdings plc SEC filings IMCR

Immunocore Holdings plc has 279 filings in SEC EDGAR's recent list, going back to Apr 13, 2016. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 14, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Immunocore Holdings plc SEC filings
Form Description Filed Period
S-8 Employee stock plan registration May 8, 2026 —
S-8 Employee stock plan registration May 7, 2025 —
424B7 427b7 Mar 17, 2025 —
424B7 Filing Apr 5, 2024 —
S-8 Employee stock plan registration Mar 21, 2024 —
S-3ASR Automatic shelf registration Mar 21, 2024 —
S-8 Employee stock plan registration Apr 6, 2023 —
424B7 Filing Sep 30, 2022 —
424B5 Prospectus supplement Sep 9, 2022 —
S-8 Employee stock plan registration May 17, 2022 —
424B7 Filing May 5, 2022 —
F-3ASR Filing Apr 4, 2022 —
S-8 Employee stock plan registration Apr 12, 2021 —
424B4 Prospectus Feb 8, 2021 —
F-1MEF Filing Feb 4, 2021 —
F-1/A Filing Feb 3, 2021 —
F-6/A Filing Feb 2, 2021 —
F-1/A Filing Feb 1, 2021 —
F-6 Filing Jan 27, 2021 —
F-1 Registration statement (foreign issuer) Jan 15, 2021 —

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
IMCR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
United Kingdom
Headquarters
Oxfordshire, United Kingdom
SEC filer status
Large accelerated filer
SEC CIK
1671927
Former names
Immunocore Ltd (until Feb 1, 2021)

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.